So, Capivasertib is this AKT inhibitor thing. It’s used for a type of breast cancer that’s HR and HER2-. It mainly focuses on those PIK3CA/AKT1/PTEN changes.
It really does a good job at stopping AKT signaling. You’ve got these tablets, 200 mg and 400 mg. They usually suggest you take 400 mg two times a day.
And the schedule goes like, four days on and then three days off. It comes in bottles, each with 64 tablets.
Reviews
There are no reviews yet.